Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov 12:7:597374.
doi: 10.3389/fcvm.2020.597374. eCollection 2020.

Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics

Affiliations
Review

Ras Pathways on Prox1 and Lymphangiogenesis: Insights for Therapeutics

Khoa Bui et al. Front Cardiovasc Med. .

Abstract

Over the past couple of decades, lymphatics research has accelerated and gained a much-needed recognition in pathophysiology. As the lymphatic system plays heavy roles in interstitial fluid drainage, immune surveillance and lipid absorption, the ablation or excessive growth of this vasculature could be associated with many complications, from lymphedema to metastasis. Despite their growing importance in cancer, few anti-lymphangiogenic therapies exist today, as they have yet to pass phase 3 clinical trials and acquire FDA approval. As such, many studies are being done to better define the signaling pathways that govern lymphangiogenesis, in hopes of developing new therapeutic approaches to inhibit or stimulate this process. This review will cover our current understanding of the Ras signaling pathways and their interactions with Prox1, the master transcriptional switch involved in specifying lymphatic endothelial cell fate and lymphangiogenesis, in hopes of providing insights to lymphangiogenesis-based therapies.

Keywords: ERK pathway; PI3K-AKT pathway; Prox1; Ras; lymphangiogenesis; lymphatics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Overview of ERK and AKT pathway on lymphangiogenesis. Both pathways influence different aspects of lymphatic remodeling upon activation of VEGFR-3, leading to downstream phosphorylation of signaling proteins (90). Crosstalk occurs across the pathways primarily as a means of negative regulation (–97). Current therapies to inhibit these signaling pathways involve the sequestration of VEGFR and its ligands (–100). Created with BioRender.com.
Figure 2
Figure 2
Prox1 protein domains and potential sites for modification. Data on sites across human, mouse, and rat Prox1 were pulled from PhosphoSitePlus (accessed October 1st, 2020). The following modification types and associated residues are: (1) Methylation (R392); (2) Sumoylation (K353, K556); (3) Acetylation (K707, K708); (4) Ubiquitylation (K212, K611, K700, K716); (5) Phosphorylation (S79, Y80, T91, T94, S142, S177, S179, S181, S197, S199, S291, S295, S372, S432, S472, S495, S511, S514, T518, S529, S530, S539, S545, S553, K557, K569, Y571, S574, T650). Created with BioRender.com.

Similar articles

Cited by

References

    1. Huxley VH, Scallan J. Lymphatic fluid: exchange mechanisms and regulation. J Physiol. (2011) 589(Pt. 12):2935–43. 10.1113/jphysiol.2011.208298 - DOI - PMC - PubMed
    1. Levick JR, Michel CC. Microvascular fluid exchange and the revised starling principle. Cardiovasc Res. (2010) 87:198–210. 10.1093/cvr/cvq062 - DOI - PubMed
    1. Liao S, Padera TP. Lymphatic function and immune regulation in health and disease. Lymphatic Res Biol. (2013) 11:136–43. 10.1089/lrb.2013.0012 - DOI - PMC - PubMed
    1. Dixon JB. Mechanisms of chylomicron uptake into lacteals. Ann N Y Acad Sci. (2010) 1207(Suppl. 1):E52–7. 10.1111/j.1749-6632.2010.05716.x - DOI - PMC - PubMed
    1. Stacker S, Williams S, Karnezis T, Shayan R, Fox S, Achen MG. Lymphangiogenesis and lymphatic vessel remodelling in cancer. Nat Rev Cancer. (2014) 14:159–72. 10.1038/nrc3677 - DOI - PubMed